NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT02163694,"A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer",https://clinicaltrials.gov/study/NCT02163694,,COMPLETED,"The primary objective of the study is to assess the progression-free survival (PFS) of veliparib in combination with carboplatin and paclitaxel (C/P) compared to placebo plus C/P in participants with a Breast Cancer Gene 1 or 2 (BRCA1; BRCA2) mutation in Human Epidermal Growth Factor Receptor 2 (HER2)-negative metastatic or locally advanced unresectable breast cancer. The secondary objectives of the study are to assess overall survival (OS), clinical benefit rate (CBR) through the end of Week 24, objective response rate (ORR) and PFS on subsequent therapy (PFS2) in participants treated with veliparib in combination with C/P versus placebo in combination with C/P.",YES,Metastatic Breast Cancer,DRUG: Veliparib Placebo|DRUG: Veliparib|DRUG: Carboplatin|DRUG: Paclitaxel,"Progression-Free Survival (PFS), Time to PFS is defined as the number of days from the date the participant was randomized to the date the participant experiences radiographic disease progression (as determined by the investigators), or to the date of death (all causes of mortality) if disease progression is not reached. All events of disease progression occurring on or before the Primary Analysis Cutoff date of 05 April 2019 were to be included, regardless of whether the event occurred while the participant was still taking study drug or had previously discontinued study drug. PFS was estimated for each treatment group using Kaplan-Meier methodology., From randomization until the primary analysis data cut-off date of 05 April 2019; the median duration of follow-up was 35.5 months","Overall Survival (OS), Time to death (overall survival) is defined as the number of days from the date the participant was randomized to the date of the participant's death. All events of death which occur up to the analysis cutoff date are to be included, regardless of whether the event occurred while the participant was still taking study drug or after the participant discontinued study drug. If a participant has not died, the data for the participant is to be censored at the date last known to be alive or at the analysis cutoff date if that is earlier.

The final analysis of OS will occur when the pre-specified number of events has occurred in the ITT population., Up to 84.5 and 81.8 months for Placebo and Veliparib, respectively.|Clinical Benefit Rate (CBR), The clinical benefit rate (CBR) is defined as the progression-free rate at 24 weeks (168 days), estimated using Kaplan Meier methodology. All events of disease progression in the primary progression free survival analysis database were to be included, regardless of whether the event occurred while the participant was still taking, or had previously discontinued, study drug. If the participant had not yet progressed then their data was to be censored at the date of the last evaluable disease progression assessment. Participants without post-baseline assessments were to be censored at the date of randomization., Through the end of Week 24|Objective Response Rate (ORR), The objective response rate (ORR) is calculated as the percentage of participants who have a confirmed partial response (PR) or complete response (CR) based on assessment by the investigators per Response Evaluation Criteria In Solid Tumors (RECIST) criteria version 1.1. All participants who had at least one measurable lesion at baseline were to be included in the ORR calculation.

The final analysis of ORR will occur when the pre-specified number of Overall Survival events have occurred in the ITT population, per the fixed sequence testing procedure., Approximately 8 years from randomization|Progression-Free Survival on Subsequent Therapy (PFS2), PFS2 is defined as the number of days from the date of randomization to the time of disease progression on subsequent therapy or death from any cause. The distribution of PFS2 was to be estimated for each treatment group using Kaplan-Meier methodology.

The final analysis of PFS2 will occur when the pre-specified number of Overall Survival events have occurred in the ITT population, per the fixed sequence testing procedure., Approximately 8 years from randomization",,AbbVie,,ALL,"ADULT, OLDER_ADULT",PHASE3,513,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",M12-914|2014-000345-70,2014-04-08,2019-04-05,2024-01-25,2014-06-16,2022-04-04,2025-03-25,"Banner MD Anderson Cancer Ctr /ID# 125011, Gilbert, Arizona, 85234, United States|University of Arkansas for Medical Sciences /ID# 124992, Little Rock, Arkansas, 72205, United States|City of Hope /ID# 127117, Duarte, California, 91010, United States|California Cancer Associates for Research & Excellence (cCARE) /ID# 136078, Fresno, California, 93720, United States|Moores Cancer Center at UC San Diego /ID# 124991, La Jolla, California, 92093, United States|Hematology and Oncology Assoc /ID# 130058, Newport Beach, California, 92663, United States|Cancer Research Collaboration /ID# 128860, Santa Ana, California, 92705, United States|Icri /Id# 128520, Whittier, California, 90603, United States|Univ of Colorado Cancer Center /ID# 124983, Aurora, Colorado, 80045, United States|Saint Joseph Hospital /ID# 131768, Denver, Colorado, 80218, United States|Norwalk Hospital /ID# 133509, Norwalk, Connecticut, 06856, United States|Lynn Cancer Institute, Boca /ID# 125013, Boca Raton, Florida, 33486, United States|Holy Cross Hospital /ID# 125012, Fort Lauderdale, Florida, 33308, United States|Sacred Heart Hospital /ID# 128279, Pensacola, Florida, 32504, United States|Moffitt Cancer Center /ID# 124990, Tampa, Florida, 33612-9416, United States|Florida Cancer Specialists - East /ID# 125007, West Palm Beach, Florida, 33401, United States|Emory Midtown Infectious Disease Clinic /ID# 133192, Atlanta, Georgia, 30322, United States|The Cancer Ctr at DeKalb Med C /ID# 125024, Decatur, Georgia, 30033, United States|University of Illinois - Chicago /ID# 127576, Chicago, Illinois, 60607, United States|NorthShore University HealthSystem /ID# 124996, Evanston, Illinois, 60201, United States|Midwestern Regional CTC /ID# 124986, Zion, Illinois, 60099, United States|McFarland Clinic, PC /ID# 129904, Ames, Iowa, 50010, United States|Johns Hopkins University /ID# 125015, Baltimore, Maryland, 21287, United States|Baystate Medical Center /ID# 139461, Springfield, Massachusetts, 01199, United States|UMass Chan Medical School /ID# 129067, Worcester, Massachusetts, 01655, United States|Henry Ford Health System /ID# 134497, Detroit, Michigan, 48202, United States|Spectrum Health Medical Group /ID# 133568, Grand Rapids, Michigan, 49503, United States|Spectrum Health Medical Group /ID# 148471, Grand Rapids, Michigan, 49503, United States|William Beaumont Hospital /ID# 125019, Royal Oak, Michigan, 48073-6710, United States|Univ of Mississippi Med Ctr,US /ID# 131352, Jackson, Mississippi, 39216-4643, United States|St. Lukes Cancer Institute /ID# 125023, Kansas City, Missouri, 64111-5905, United States|Washington University-School of Medicine /ID# 127575, Saint Louis, Missouri, 63110, United States|Nebraska Hematology Oncology /ID# 132711, Lincoln, Nebraska, 68506, United States|Rutgers Cancer Institute of New Jersey /ID# 125017, New Brunswick, New Jersey, 08901, United States|University of New Mexico /ID# 125349, Albuquerque, New Mexico, 87102-4517, United States|Beth Israel Medical Center /ID# 125001, New York, New York, 10003, United States|Mount Sinai St. Luke's /ID# 125003, New York, New York, 10025, United States|Mission Cancer Center /ID# 134248, Asheville, North Carolina, 28801, United States|Duke Cancer Center /ID# 124999, Durham, North Carolina, 27710-3000, United States|The Ohio State University /ID# 125022, Columbus, Ohio, 43210, United States|University of Toledo /ID# 134849, Toledo, Ohio, 43614, United States|Oregon Health and Science University /ID# 134229, Portland, Oregon, 97239, United States|Lehigh Valley Health Network /ID# 130059, Allentown, Pennsylvania, 18103, United States|Lehigh Valley Hosp/Muhlenberg /ID# 130277, Bethlehem, Pennsylvania, 18017, United States|Penn State University and Milton S. Hershey Medical Center /ID# 124997, Hershey, Pennsylvania, 17033, United States|Allegheny General Hospital /ID# 135094, Pittsburgh, Pennsylvania, 15212, United States|University of Pittsburgh MC /ID# 125005, Pittsburgh, Pennsylvania, 15260, United States|Texas Health Physicians Group /ID# 137740, Arlington, Texas, 76012, United States|University of Texas Southwestern Medical Center /ID# 124989, Dallas, Texas, 75390-7208, United States|University of Texas MD Anderson Cancer Center /ID# 125353, Houston, Texas, 77030, United States|University of Vermont Medical Center /ID# 125350, Burlington, Vermont, 05401-1473, United States|Swedish Cancer Institute - Issaquah /ID# 131534, Issaquah, Washington, 98029-6201, United States|Swedish Cancer Institute - Edmonds /ID# 131549, Seattle, Washington, 98104, United States|Swedish Medical Center /ID# 125021, Seattle, Washington, 98104, United States|Swedish Cancer Insititute - Ballard /ID# 131548, Seattle, Washington, 98107-3932, United States|Northwest Medical Specialties - Tacoma /ID# 125344, Tacoma, Washington, 98405, United States|COIBA Centro de Oncologia e Investigacion de Buenos Aires /ID# 124839, Berazategui, Buenos Aires, 1884, Argentina|Clinica Pergamino /ID# 127158, Pergamino, Buenos Aires, 2700, Argentina|Instituto de Oncoloia de Rosario /ID# 127157, Rosario, Santa Fe, 2000, Argentina|Centro Oncologico Riojano Integral /ID# 127938, La Rioja, 5300, Argentina|St George Hospital /ID# 129416, Kogarah, New South Wales, 2217, Australia|Duplicate_The Prince of Wales Hospital /ID# 124845, Randwick, New South Wales, 2031, Australia|Southern Medical Day Care Centre /ID# 124844, Wollongong, New South Wales, 2500, Australia|Townsville University Hospital /ID# 126731, Douglas, Queensland, 4814, Australia|Duplicate_Flinders Centre for Innovation /ID# 127535, Bedford Park, South Australia, 5042, Australia|Royal Hobart Hospital /ID# 124849, Hobart, Tasmania, 7000, Australia|The Royal Melbourne Hospital /ID# 124846, Parkville, Victoria, 3050, Australia|Hollywood Private Hospital /ID# 124843, Nedlands, Western Australia, 6009, Australia|Ordensklinikum Linz GmbH Elisabethinen /ID# 126185, Linz, Oberoesterreich, 4010, Austria|Medizinische Universitaet Graz /ID# 126450, Graz, Steiermark, 8036, Austria|Medizinische Universitaet Wien /ID# 126184, Vienna, Wien, 1090, Austria|Landeskrankenhaus Salzburg-Universitätsklinikum der PMU (LKH) /ID# 126449, Salzburg, 5020, Austria|Bobruysk Interdistrict Onco. /ID# 137729, Bobruisk, 213825, Belarus|State Institution Republican Scientific Practical Center of Oncology and Medical /ID# 125223, Minsk, 223040, Belarus|Duplicate_Mogilev Reg Clin Oncology Dis /ID# 137728, Mogilev, 212018, Belarus|Vitebsk Regional Clinical Oncology Dispensary /ID# 125219, Vitebsk, 210603, Belarus|Universitair Ziekenhuis Antwerpen /ID# 124977, Edegem, Antwerpen, 2650, Belgium|UCL Saint-Luc /ID# 124976, Woluwe-Saint-Lambert, Bruxelles-Capitale, 1200, Belgium|Grand Hôpital de Charleroi /ID# 124981, Charleroi, Hainaut, 6000, Belgium|Universitair Ziekenhuis Leuven /ID# 124980, Leuven, Vlaams-Brabant, 3000, Belgium|Duplicate_AZ St-Jan Brugge-Oostende AV /ID# 124975, Brugge, West-Vlaanderen, 8000, Belgium|ZNA Middelheim /ID# 124978, Antwerp, 2020, Belgium|CHU UCL Namur - Sainte Elisabeth /ID# 124979, Namur, 5000, Belgium|Duplicate_Sunnybrook Health Sciences Ctr /ID# 124882, Toronto, Ontario, M4N 3M5, Canada|Duplicate_Jewish General Hospital /ID# 124880, Montreal, Quebec, H3T 1E2, Canada|CHUM - Notre-Dame Hospital /ID# 124879, Montréal, Quebec, H2X 0A9, Canada|Duplicate_CHUQ-Hospital St. Sacrement /ID# 124881, Quebec City, Quebec, G1S 4L8, Canada|Hospital Clinico Vina del Mar /ID# 130100, Vina Del Mar, Valparaíso, 2520612, Chile|Hospital Clinico Vina del Mar /ID# 148502, Vina Del Mar, Valparaíso, 2520612, Chile|Instituto Nacional del Cancer /ID# 129343, Santiago, 8380455, Chile|ICOS - Inst Clinic Oncology /ID# 125236, Temuco, 4810469, Chile|Hospital Pablo Tobon Uribe /ID# 126657, Medellín, Antioquia, 50034, Colombia|Instituto Medico de Alta Tecnologia Oncomédica S.A /ID# 129211, Monteria, Cordoba, 230002, Colombia|Administradora del Country_S.A-Clinica Del Country /ID# 125255, Bogota, Cundinamarca, 110221, Colombia|Hospital Univ San Ignacio /ID# 126655, Bogota, Cundinamarca, 110231, Colombia|Centro Medico Imbanaco de Cali /ID# 126656, Cali, Colombia|Fakultni Nemocnice Brno /ID# 128176, Brno, 625 00, Czechia|Masarykuv onkologicky ustav /ID# 124886, Brno, 656 53, Czechia|Duplicate_FN Hradec Kralove /ID# 127080, Hradec Kralove, 500 05, Czechia|Fakultni nemocnice Olomouc /ID# 124885, Olomouc, 779 00, Czechia|Vseobecna fakultni nemocnice v Praze /ID# 124887, Praha, 128 08, Czechia|Rigshospitalet /ID# 124891, Copenhagen Ø, Hovedstaden, 2100, Denmark|Sygehus Lillebælt, Vejle /ID# 124892, Vejle, Syddanmark, 7100, Denmark|East Tallinn Central Hospital /ID# 126475, Kesklinna Linnaosa, Harjumaa, 10138, Estonia|Docrates Cancer Center /ID# 124896, Helsinki, 00180, Finland|Duplicate_Helsinki Univ Central Hospital /ID# 124897, Helsinki, 00290, Finland|Duplicate_Tampere University Hospital /ID# 124898, Tampere, 33521, Finland|Vaasa Central Hospital /ID# 132548, Vaasa, 65130, Finland|Institut Paoli-Calmettes /ID# 124903, Marseille, Bouches-du-Rhone, 13009, France|Institut Curie /ID# 124902, Paris CEDEX 05, Ile-de-France, 75248, France|Institut de Cancérologie de l'Ouest René Gauducheau /ID# 137726, St Herblain CEDEX, Loire-Atlantique, 44805, France|Institut Curie - site CLCC René Huguenin /ID# 124904, Saint-cloud, 92210, France|Universitaetsklinik Heidelberg /ID# 126664, Heidelberg, Baden-Wuerttemberg, 69120, Germany|Universitaetsklinimum Tuebingen /ID# 129968, Tubingen, Baden-Wuerttemberg, 72076, Germany|Universitaetsklinikum Ulm /ID# 135230, Ulm, Baden-Wuerttemberg, 89081, Germany|Universitaetsklinikum Koeln /ID# 126905, Köln, Nordrhein-Westfalen, 50937, Germany|Universitaetsklinikum Carl Gustav Carus an der TU Dresden /ID# 127180, Dresden, 01307, Germany|Klinikum rechts der Isar - Technische Universitaet Muenchen /ID# 125256, Munich, 81675, Germany|Sana Klinikum Offenbach /ID# 126733, Offenbach am Main, 63069, Germany|Semmelweis Egyetem /ID# 132485, Budapest, 1085, Hungary|Pecsi Tudomanyegyetem Klinikai Kozpont /ID# 125259, Pecs, 7624, Hungary|Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz /ID# 124911, Szolnok, 5000, Hungary|Duplicate_Zala Megyei Korhaz /ID# 131341, Zalaegerszeg, 8900, Hungary|The Chaim Sheba Medical Center /ID# 124918, Ramat Gan, Tel-Aviv, 5265601, Israel|Tel Aviv Sourasky Medical Center /ID# 130276, Tel Aviv-Yafo, Tel-Aviv, 6423906, Israel|Duplicate_Soroka University Medical Center /ID# 124917, Be'er Sheva, 8457101, Israel|Assaf Harofeh Medical Center /ID# 124915, Be'Er Ya'Akov, 70300, Israel|Rambam Health Care Campus /ID# 124916, Haifa, 3109601, Israel|Shaare Zedek Medical Center /ID# 130275, Jerusalem, 91031, Israel|Gastroenterology Institute, Division of Medicine /ID# 124919, Jerusalem, 91120, Israel|Kaplan Medical Center /ID# 124914, Rehovot, 7661041, Israel|Ospedale San Raffaele IRCCS /ID# 125261, Milan, Lombardia, 20132, Italy|IEO -Istituto Europeo di Oncologia /ID# 125260, Milan, Milano, 20141, Italy|IRCCS Ospedale Sacro Cuore Don Calabria /ID# 125262, Negrar, Verona, 37024, Italy|Centro di Riferimento Oncologico /ID# 126738, Aviano, 33081, Italy|Grande Ospedale Metropolitano Bianchi Melacrino Morelli /ID# 125263, Reggio Calabria, 89124, Italy|National Cancer Center /ID# 125602, Goyang, Gyeonggido, 10408, Korea, Republic of|Yonsei University Health System Severance Hospital /ID# 125599, Seoul, Seoul Teugbyeolsi, 03722, Korea, Republic of|Korea University Anam Hospital /ID# 128968, Seoul, 02841, Korea, Republic of|Seoul National University Hospital /ID# 125600, Seoul, 03080, Korea, Republic of|Asan Medical Center /ID# 125601, Seoul, 05505, Korea, Republic of|Samsung Medical Center /ID# 125598, Seoul, 06351, Korea, Republic of|Pauls Stradins Clinical University Hospital /ID# 125264, Riga, 1002, Latvia|Riga East Clinical University Hospital /ID# 125265, Riga, LV-1079, Latvia|Hospital of Lithuanian University of Health Sciences Kaunas Clinics /ID# 125266, Kaunas, 50161, Lithuania|National Cancer Institute /ID# 125267, Vilnius, 08660, Lithuania|Centro de Estudios Clínicos Especializados /ID# 128680, Mérida, Yucatan, 97133, Mexico|Centro Oncologico de Chihuahua /ID# 128679, Chihuahua, 31217, Mexico|Instituto Nacional de Cancerología INCAN /ID# 128676, Ciudad de Mexico, 14080, Mexico|Erasmus Medisch Centrum /ID# 124935, Rotterdam, Zuid-Holland, 3015 GD, Netherlands|Universitair Medisch Centrum Groningen /ID# 129069, Groningen, 9713 GZ, Netherlands|Maastricht Universitair Medisch Centrum /ID# 129068, Maastricht, 6229 HX, Netherlands|Haukeland University Hospital /ID# 150177, Bergen, Hordaland, 5021, Norway|Wojewodzki Szpital Specjalistyczny /ID# 127258, Wroclaw, Dolnoslaskie, 51-124, Poland|Centrum Onkologii Lukaszczyka /ID# 124938, Bydgoszcz, Kujawsko-pomorskie, 85-796, Poland|Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopern /ID# 126999, Lodz, Lodzkie, 93-513, Poland|MRUK-MED I Spolka z ograniczona odpowiedzialnoscia /ID# 124939, Rzeszow, Podkarpackie, 35-021, Poland|Wojewodzki Szpital Zespolony /ID# 126998, Elblag, Warminsko-mazurskie, 82-300, Poland|Centro Hospitalar de Vila Nova de Gaia/Espinho, EPE /ID# 126510, Vila Nova De Gaia, Porto, 4434-502, Portugal|Centro Hospitalar Universitário do Algarve, EPE - Hospital Faro /ID# 125298, Faro, 8000-386, Portugal|Centro Hospitalar Universitário de Lisboa Norte, EPE - Hospital de Santa Maria /ID# 125299, Lisboa, 1649-035, Portugal|Unidade Local de Saúde de Matosinhos, EPE /ID# 126511, Matosinhos, 4464-513, Portugal|IPO Porto FG, EPE /ID# 125297, Porto, 4200-072, Portugal|Centro Hospitalar Universitario de Sao Joao, EPE /ID# 126508, Porto, 4200-319, Portugal|Ad-Vance Medical Research, LLC /ID# 126043, Ponce, 00717, Puerto Rico|San Juan Municipal Hospital /ID# 124695, San Juan, 00935, Puerto Rico|S.C. Centrul de Oncologie Sf. Nectarie S.R.L. /ID# 124948, Craiova, Dolj, 200347, Romania|Duplicate_lnstitutul Oncologic Prof Dr Alexandru Trestioreanu /ID# 124943, Bucharest, 022328, Romania|Spitalul Clinic Judetean de Urgenta Cluj -Napoca /ID# 124945, Cluj-Napoca, 400006, Romania|Oncomed SRL /ID# 127598, Timisoara, 300239, Romania|Sverdlovsk Regional Oncology Dispensary /ID# 130950, Yekaterinburg, Sverdlovskaya Oblast, 620043, Russian Federation|Regional Oncology Dispensary /ID# 125936, Kursk, Tatarstan, Respublika, 305035, Russian Federation|Duplicate_archangel Clinical Oncology /ID# 126031, Arkhangelsk, 163045, Russian Federation|Altay Regional Oncological Dispesary /ID# 127160, Barnaul, 656049, Russian Federation|Belgorod Oncology Dispensary /ID# 129315, Belgorod, 308010, Russian Federation|Duplicate_Saratov State Medical University n.s. Chernyshevskiy /ID# 139395, Saratov, 410012, Russian Federation|LLC BioEq Ltd. /ID# 134529, St. Petersburg, 197342, Russian Federation|Siberian State Medical University /ID# 127161, Tomsk, 634050, Russian Federation|Volgograd Regional Clinical Oncology Dispensary /ID# 124952, Volzhsky, 404130, Russian Federation|National University Hospital /ID# 125315, Singapore, 119074, Singapore|Johns Hopkins Singapore IMC /ID# 125316, Singapore, 308433, Singapore|GVI Oncology /ID# 125321, Gqeberha, Eastern Cape, 6006, South Africa|University of Free State, Universitas Annex (National Hospital Grounds) /ID# 128499, Bloemfontein, Free State, 9301, South Africa|Wits Clinical Research Site /ID# 125317, Johannesburg, Gauteng, 2193, South Africa|Medical Oncology Ctr Rosebank /ID# 125322, Johannesburg, Gauteng, 2196, South Africa|Sandton Oncology Medical Group PTY Ltd /ID# 125323, Johannesburg, Gauteng, 2196, South Africa|Mary Potter Oncology Centre /ID# 133269, Pretoria, Gauteng, 0181, South Africa|The Oncology Centre /ID# 126104, Durban, Kwazulu-Natal, 4091, South Africa|Netcare Oncology Intervent Ctr /ID# 125320, Cape Town, Western Cape, 7460, South Africa|Cancercare Outeniqua Oncology Centre /ID# 125319, George, Western Cape, 6530, South Africa|Hospital Santa Creu i Sant Pau /ID# 124963, Barcelona, 08041, Spain|Hospital General Universitario Gregorio Maranon /ID# 124962, Madrid, 28007, Spain|Hospital Universitario HM Sanchinarro /ID# 124960, Madrid, 28050, Spain|Hospital Universitario Virgen de la Victoria /ID# 124961, Malaga, 29010, Spain|Hospital Clinico Universitario de Valencia /ID# 124959, Valencia, 46010, Spain|Skane University hospital /ID# 124966, Malmo, Skane Lan, 214 28, Sweden|Norrlands University hospital /ID# 124967, Umea, Vasterbottens Lan, 581 85, Sweden|Sahlgrenska University Hospital /ID# 124965, Gothenburg, Vastra Gotalands Lan, 413 45, Sweden|Linkoping University Hospital /ID# 126795, Linkoping, 581 85, Sweden|Duplicate_Karolinska Univ Sjukhuset /ID# 124964, Solna, 171 64, Sweden|Uppsala University Hospital /ID# 126512, Uppsala, 75185, Sweden|Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 125575, Kaohsiung, 807, Taiwan|National Taiwan University Hospital /ID# 125324, Taipei City, 100, Taiwan|Hacettepe University Faculty of Medicine /ID# 125336, Ankara, 06100, Turkey|Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi /ID# 125337, Ankara, 06200, Turkey|Duplicate_Akdeniz University Medical Fac /ID# 125339, Antalya, 07059, Turkey|Bezmi Alem Univ Med Fac Hosp /ID# 127901, Istanbul, 34093, Turkey|Istanbul University Istanbul Medical Faculty /ID# 145144, Istanbul, 34093, Turkey|Municipal Non-Profit Enterprise City Clinical Hospital No.4 of Dnipro City Counc /ID# 124968, Dnipro, 49102, Ukraine|Donetsk Regional Antitumor Ctr /ID# 124970, Donetsk, 83092, Ukraine|Communal non-profit enterprise Regional Center of Oncology /ID# 124972, Kharkiv, 61070, Ukraine|Lviv Oncological Regional Therapeutical and Diagnostic Centre /ID# 124974, Lviv, 79031, Ukraine|Poltava Regional Clinical Oncology Centre of Poltava Regional Council /ID# 124969, Poltava, 36011, Ukraine|Zaporizhzhia Med. Academy MOH /ID# 129800, Zaporizhia, 69040, Ukraine|ME Kryviy Rih Oncology Dispensary /ID# 129806, Кривий Ріг, 50048, Ukraine|University Hospitals Bristol /ID# 128343, Bristol, Bristol, City Of, BS2 8ED, United Kingdom|Hull University Teaching Hospitals NHS Trust /ID# 133030, Hull, East Riding Of Yorkshire, HU3 2JZ, United Kingdom|Nottingham University Hospitals NHS Trust /ID# 125340, Nottingham, Nottinghamshire, NG5 1PB, United Kingdom|University Hospitals Birmingham NHS Foundation Trust /ID# 125342, Birmingham, B15 2TH, United Kingdom","Study Protocol, https://cdn.clinicaltrials.gov/large-docs/94/NCT02163694/Prot_000.pdf|Statistical Analysis Plan, https://cdn.clinicaltrials.gov/large-docs/94/NCT02163694/SAP_001.pdf"
